Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6543859 | 1.00 | ALDH1A1 (0.49) | ALDH1A1TP53TSHRHTTPOLB | |
| Hydrochloric Acid SCHEMBL6544280 | 0.98 | ALDH1A1 (0.48) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL8177031 | 0.98 | ALDH1A1 (0.46) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL6544388 | 0.94 | ALDH1A1 (0.43) | ALDH1A1TP53TSHRHTTPOLB | |
| Formic Acid SCHEMBL3898988 | 0.93 | ALDH1A1 (0.44) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL5200587 | 0.85 | ALDH1A1 (0.42) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL28650457 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL30562291 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL10002524 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TP53TSHRHTTPOLB | |
| SCHEMBL5633342 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TP53TSHRHTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140127326-A1 | Detection of Cancer by Volatile Organic Compounds From Breath | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2014-05-08 | — | — | US | claimed |
| EP-2354133-B1 | Method for producing 1-(3-Cyano-3,3-diphenylpropyl)-4-(1-piperidyl)-piperidine-4-carboxamide (Piritramide) | HAMELN RDS GMBH (DE) | 2013-12-11 | — | — | EP | claimed |
| WO-2012122128-A2 | DETECTION OF CANCER BY VOLATILE ORGANIC COMPOUNDS FROM BREATH | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-09-13 | — | — | WO | claimed |
| EP-2354133-A1 | Method for producing 1-(3-Cyano-3,3-diphenylpropyl)-4-(1-piperidyl)-piperidine-4-carboxamide (Piritramide) | hameln rds gmbh (DE) | 2011-08-10 | — | — | EP | claimed |
| EP-0739891-B1 | Substituted heterocycles | ASTRAZENECA AB (SE) | 2005-01-19 | — | — | EP | claimed |
| EP-0739891-A2 | Substituted heterocycles | ZENECA LIMITED (GB) | 1996-10-30 | — | — | EP | claimed |
| JP-58085882-A | — | — | None | — | — | JP | disclosed |
| JP-5043577-A | — | — | None | — | — | JP | disclosed |
| US-12552732-B2 | Cyclopropanated sandalwood type compounds | SYMRISE AG (DE) | 2026-02-17 | — | — | US | disclosed |
| US-20250281661-A1 | EMULSIONS FOR USE IN AIR FRESHENERS DEVICES | SYMRISE AG (DE) | 2025-09-11 | — | — | US | disclosed |
| EP-4347757-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | disclosed |
| WO-2024028513-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | SYMRISE AG (DE) | 2024-02-08 | — | — | WO | disclosed |
| WO-2024027931-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | SYMRISE AG (DE) | 2024-02-08 | — | — | WO | disclosed |
| US-5350743-A | Treatment of osteoporosis | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1994-09-27 | — | — | US | disclosed |
| JP-H0543577-A | PRODUCTION OF (+-)-2-OXO-2,3,5,6,7,8-HEXAHYDROIMIDAZO(1,2-A) PYRIDINE-3-SPIRO-4'-PIPERIDINE | YOSHITOMI PHARMACEUT IND LTD | 1993-02-23 | — | — | JP | disclosed |
| EP-0498424-A1 | Bisphosphonic acid derivatives and bone resorption inhibitors containing them | Kaken Pharmaceutical Co., Ltd. (JP) | 1992-08-12 | — | — | EP | disclosed |
| EP-0073845-B1 | IMIDAZOPYRIDINE-SPIRO-PIPERIDINE COMPOUNDS | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1985-05-29 | — | — | EP | disclosed |
| JP-S5885882-A | NOVEL DIBENZAZEPIN DERIVATIVE | YOSHITOMI PHARMACEUT IND LTD | 1983-05-23 | — | — | JP | disclosed |
| EP-0073845-A1 | Imidazopyridine-spiro-piperidine compounds | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1983-03-16 | — | — | EP | disclosed |
| US-4337260-A | ANTIDEPRESSANT, SEDATIVE | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1982-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552732-B2 | Cyclopropanated sandalwood type compounds | FAAH2, ADCY10, OR10J3 | ALDH1A1 8/4885TP53 3907/4885TSHR 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.